Share Price:

APNASPENAspen Pharmacare Hldgs12770109 (0.86%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

Aspen launches its 2025 Integrated Report and retains Level 4 B-BBEE status

We’re proud to announce the release of our 2025 Integrated Report and Supplementary Documents, showcasing how Aspen continues to deliver on its purpose β€” improving the health and quality of life of patients while creating sustainable value for our stakeholders.

Our 2025 reporting suite highlights our governance, sustainability impact, strategic objectives and operational performance, reflecting the teamwork, innovation, and integrity that define Aspen.

In addition, Aspen has successfully completed its B-BBEE verification, retaining its Level 4 status in line with the Codes of Good Practice β€” reaffirming our commitment to transformation, inclusivity, and empowerment.

β€œThis past year has tested our resilience as we navigated a series of unprecedented challenges across our operating environment, requiring decisive action and unwavering commitment to our purpose. The Board is confident that the strategic measures underway will restore profitability and position the Group for sustainable growth in line with our medium to long-term objectives.” β€” Kuseni Dlamini, Board Chair


Explore our 2025 Integrated Report and Supplementary Documents on our website to learn how we continue to create long-term value for our stakeholders.
https://lnkd.in/fR2QcDx

IR-2025.jpg
Facebook
Twitter
LinkedIn
Pinterest

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: